In today's Just The Facts..
Lindian Resources has hosted senior US Government officials at its Kangankunde rare earths project in Malawi, highlighting development progress and its potential role in supplying high-grade rare earths to global markets, amid growing US focus on securing critical mineral supply chains.
Prescient Therapeutics has secured European authorisation to begin its PTX-100 clinical trial in Italy, enabling patient recruitment for a Phase 2a study in relapsed or refractory cutaneous T-cell lymphoma, as the company advances its first-in-class cancer therapy into Europe.
Tamboran Resources has completed stimulation of its Shenandoah South 6H well in the Beetaloo Basin, with cost-saving optimisations applied, as the company prepares for flowback and a 30-day production test scheduled for early 2026.
#RareEarths #CriticalMinerals #EnergyTransition #USSupplyChains #AfricaMining #Biotech #ClinicalTrials #Oncology #CancerResearch #TamboranResources #ASX #EnergyNews #NaturalGas #OilAndGas